Indications for fetal surveillanceIn June of 2021, the American College of Obstetrics and Gynecology and the Society for Maternal-Fetal Medicine published a joint committee opinion outlining indications for antepartum fetal surveillance. The document suggests surveillance for conditions for which stillbirth is reported to occur more frequently than 0.8 per 1,000 and which are associated with [...]

July 2021 Updates from NJPA COVID-19 Vaccination COVID-19 vaccines are critical for ending the COVID-19 pandemic. Pregnant women are at increased risk for severe illness and death from COVID-19 compared with nonpregnant women of reproductive age. Pregnant women with COVID-19 are also at increased risk of adverse pregnancy outcomes such as preterm birth and [...]

March 2021 Updates from NJPA COVID-19 On March 11, 2020, the World Health Organization declared the COVID‐19 outbreak (caused by SARS‐CoV‐2) a pandemic. Communication from the CDC, SMFM and ACOG to obstetric care providers about COVID‐19 and how best to advise and manage pregnant patients is imperative and rapidly evolving. With regard to COVID‐19 [...]

February 2020 Updates from NJPA In this newsletter… Update on Prophylactic 17-OHPC (Makena)  Update on fetal echocardiogram indications Meet our perinatologist  Update on Prophylactic 17 OH Progesterone Caproate  Recurrent spontaneous preterm birth (sPTB) is a major public health problem. It is defined as spontaneous delivery prior to 37 weeks of gestation and is associated with [...]

August 2019 Updates from NJPA In this newsletter… Elective Induction of Labor in Low-Risk Nulliparous Women at Term: The ARRIVE Trial  Centers for Disease Control and Prevention (CDC) updates Zika virus and pregnancy recommendations Meet our perinatologist  Elective Induction of Labor at Term  Historically, elective induction of labor has been regarded as harmful with a [...]

June 2018 Updates from NJPA In this newsletter… Perinatal Hepatitis B Prevention Genetics Corner Meet our Perinatologist Perinatal Hepatitis B Prevention Between 800,000-1.4 million people in the United States and more than 240 million people worldwide are infected with hepatitis B virus (HBV). Specific to pregnancy, an estimated prevalence of 0.7-0.9% for chronic HBV infection [...]

March 2018 Updates from NJPA In this newsletter… Medical management of gestational diabetes Genetics Corner Meet our perinatologist Medical Management of Gestational Diabetes In February of 2018, the American Congress of Obstetrics and Gynecology (ACOG), released an updated practice bulletin of gestational diabetes mellitus (GDM). One of the most significant updates in this document pertains [...]

October 2017 Updates from NJPA In this newsletter… Updates on Zika virus  Genetics Corner  Meet our perinatologist Zika Virus Testing Updates  On July 24, 2017, the Center for Disease Control (CDC) yet again revised its guidelines for the caring of pregnant women with possible Zika virus infection. Recommendations that did not change include:  Pregnant women [...]

Maternal Obesity and Pregnancy Outcomes    In this newsletter… Maternal Obesity and Pregnancy Outcomes Genetics Corner Meet our Perinatologist Obesity is commonly classified based on body mass index (BMI), defined as weight in kilograms divided by height in meters squared. The World Health Organization organizes BMI ranging into six categories to define underweight (BMI ≤18), [...]

NJPA August 2014 Newsletter In this newsletter… Maternal obesity and adverse obstetric outcomes New Jersey Top Hospitals for High Risk Pregnancy Meet our perinatologist Maternal Obesity and Adverse Obstetric Outcomes In the United States, the prevalence of obesity has increased tremendously over the last few decades. Among pregnant women, obesity is also a growing health [...]